查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032451

大容量注射劑市場報告：按類型、容量、應用、最終用戶和地區分類（2026-2034 年）

Large Volume Parenteral Market Report by Type, Volume, Application, End Users, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球大容量注射用蛋白丙醇（LVP）市場規模達109億美元。展望未來，IMARC Group預測，該市場從2026年到2034年將以5.13%的複合年成長率成長，到2034年達到174億美元。

大容量注射（LVP）是指經熱滅菌處理後，灌裝於容量為100毫升或以上的玻璃瓶或軟包裝容器內的單劑量注射劑。它們透過皮膚或其他體外組織注射，將活性成分直接輸送到血管、器官、組織或病灶。 LVP通常由活性成分、水溶性或非水溶性溶劑以及添加劑組成，例如緩衝劑、抗氧化劑、防腐劑、界面活性劑、抗菌劑和滲透調節劑。全球常用的大容量注射劑包括腹膜透析液、灌洗液、血液製品、藥物預混合料和造影。

大容量注射（LVP）市場趨勢：

全球營養不良加劇、出生率上升以及早產率上升是推動低熔點蛋白（LVP）需求成長的主要因素，LVP 可用於為經口進食困難的患者提供大量營養。此外，LVP 也廣泛用於為食道阻塞、胃腸道疾病、癌症和潰瘍患者提供必需營養素。 LVP 也廣泛用於心血管手術，以防止再灌注或血流限制期間心肌缺血性損傷。此外，接受手術的患者對安全、快速、有效的藥物輸送方式的需求不斷成長，也促進了市場成長。而且，全球快餐消費量的增加導致高血壓、糖尿病、肥胖症和其他代謝紊亂等非傳染性疾病病例的增加。因此，LVP（一種由葡萄糖、胺基酸、脂質、添加電解質、微量元素和維生素組成的混合物）的應用正在推廣。

競爭格局：

此外，還調查了該行業的競爭格局，並介紹了主要公司的概況，包括 Albert David Ltd.、B. Braun Melsungen AG、Baxter International Inc.、BML Parenteral Drugs、Fresenius Kabi AG、Grifols SA、Otsuka Pharmaceutical Co. Ltd、Pharmaceutical Solutions Industry Ltd.、 Fisher 有限公司和四科川。

本報告解答的主要問題：

  • 迄今為止，全球大容量注射磷酸鹽（LVP）市場的發展趨勢是什麼？您預計未來幾年這些趨勢將如何發展？
  • COVID-19 對全球大容量注射預防藥物（LVP）市場產生了哪些影響？
  • 主要區域市場有哪些？
  • 按類型分類的市場組成是什麼？
  • 按產能分類，市場組成如何？
  • 按應用領域分類的市場區隔如何？
  • 依最終用戶分類的市場區隔如何？
  • 該產業價值鏈包含哪些不同階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球大容量注射（LVP）市場的結構是怎麼樣的？主要參與者有哪些？
  • 這個行業的競爭有多激烈？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球大容量注射劑市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 軟包 LVP
  • 塑膠瓶（LVP）
  • 玻璃瓶 LVP

第7章 市場區隔：依銷售量

  • 100 mL-250 mL
  • 250 mL～500 mL
  • 500 mL～1000 mL
  • 1000 mL-2000 mL
  • 2000毫升或以上

第8章 市場區隔：依應用領域分類

  • 治療性注射
  • 輸液調節體液平衡
  • 營養注射

第9章 市場區隔：依最終用戶分類

  • 醫院
  • 診所
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Albert David Ltd.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • BML Parenteral Drugs
    • Fresenius Kabi AG
    • Grifols SA
    • Otsuka Pharmaceutical Co. Ltd
    • Pharmaceutical Solutions Industry Ltd.
    • Sichuan Kelun Pharmaceutical Co., Ltd.
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A5711

The global large volume parenteral (LVP) market size reached USD 10.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 17.4 Billion by 2034, exhibiting a growth rate (CAGR) of 5.13% during 2026-2034.

A large volume parenteral (LVP) is a single-dose injection packaged in a glass bottle or a flexible container of more than 100ml capacity after sterilization via heat. It is injected through the skin or other external boundary tissue to directly administrate the active drug substances into the blood vessels, organs, tissues, or lesions. It generally consists of an active ingredient, water-miscible or non-aqueous vehicle, and added substances like buffers, antioxidants, preservatives, surfactants, antimicrobial agents, and tonicity adjusters. Some of the commonly available LVPs around the world are peritoneal dialysis, irrigating solutions, blood derivatives, drug premixes, and contrast agents.

Large Volume Parenteral (LVP) Market Trends:

The rising prevalence of malnutrition, growing natality rate, and increasing premature births worldwide are among the key factors catalyzing the demand for LVPs to administer a large amount of nutrients in patients who are unable to take food orally. Apart from this, they are widely used in administering essential nutrients to patients undergoing treatment for esophageal obstruction, gastrointestinal (GI) diseases, cancer, and ulcer. In addition, LVPs find extensive application in heart surgery to prevent ischemic injury to the myocardium during reperfusion and the blood flow supply restriction. This, in confluence with the escalating demand for safe, fast, and effective methods of drug administration among patients undergoing surgical interventions, is contributing to the market growth. Besides this, the growing consumption of fast food across the globe has resulted in rising instances of non-communicable diseases, such as hypertension, diabetes, obesity, and other metabolic disorders. This, in turn, is positively influencing the adoption of LVPs that are a mixture of dextrose, amino acids, lipids, added electrolytes, trace metals, and vitamins.

Market Segmentation:

This report provides an analysis of the key trends in each sub-segment of the global large volume parenteral (LVP) market report, along with forecasts at the global, regional and country level from 2026-2034. The report categorizes the market based on type, volume, application and end users.

Breakup by Type:

  • Soft Bag LVP
  • Plastic Bottle LVP
  • Glass Bottle LVP

Breakup by Volume:

  • 100 ML - 250 ML
  • 250 ML - 500 ML
  • 500 ML - 1000 ML
  • 1000 ML - 2000 ML
  • 2000 ML and More

Breakup by Application:

  • Therapeutic Injections
  • Fluid Balance Injections
  • Nutritious Injections

Breakup by End Users:

  • Hospitals
  • Clinics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Albert David Ltd., B. Braun Melsungen AG, Baxter International Inc., BML Parenteral Drugs, Fresenius Kabi AG, Grifols S.A, Otsuka Pharmaceutical Co. Ltd, Pharmaceutical Solutions Industry Ltd., Sichuan Kelun Pharmaceutical Co. Ltd. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global large volume parenteral (LVP) market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global large volume parenteral (LVP) market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the volume?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end users?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global large volume parenteral (LVP) market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Large Volume Parenteral (LVP) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Soft Bag LVP
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Plastic Bottle LVP
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Glass Bottle LVP
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Volume

  • 7.1 100 ML - 250 ML
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 250 ML - 500 ML
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 500 ML - 1000 ML
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 1000 ML - 2000 ML
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 2000 ML and More
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Therapeutic Injections
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Fluid Balance Injections
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nutritious Injections
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End Users

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Albert David Ltd.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 B. Braun Melsungen AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Baxter International Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 BML Parenteral Drugs
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Fresenius Kabi AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Grifols S.A
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Otsuka Pharmaceutical Co. Ltd
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Pharmaceutical Solutions Industry Ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Sichuan Kelun Pharmaceutical Co., Ltd.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Thermo Fisher Scientific Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Large Volume Parenteral Market: Major Drivers and Challenges
  • Figure 2: Global: Large Volume Parenteral Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Large Volume Parenteral Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Large Volume Parenteral Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Large Volume Parenteral Market: Breakup by Volume (in %), 2025
  • Figure 6: Global: Large Volume Parenteral Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Large Volume Parenteral Market: Breakup by End Users (in %), 2025
  • Figure 8: Global: Large Volume Parenteral Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Large Volume Parenteral (Soft Bag LVP) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Large Volume Parenteral (Soft Bag LVP) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Large Volume Parenteral (Plastic Bottle LVP) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Large Volume Parenteral (Plastic Bottle LVP) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Large Volume Parenteral (Glass Bottle LVP) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Large Volume Parenteral (Glass Bottle LVP) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Large Volume Parenteral (100 ML - 250 ML) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Large Volume Parenteral (100 ML - 250 ML) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Large Volume Parenteral (250 ML - 500 ML) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Large Volume Parenteral (250 ML - 500 ML) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Large Volume Parenteral (500 ML - 1000 ML) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Large Volume Parenteral (500 ML - 1000 ML) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Large Volume Parenteral (1000 ML - 2000 ML) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Large Volume Parenteral (1000 ML - 2000 ML) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Large Volume Parenteral (2000 ML and More) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Large Volume Parenteral (2000 ML and More) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Large Volume Parenteral (Therapeutic Injections) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Large Volume Parenteral (Therapeutic Injections) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Large Volume Parenteral (Fluid Balance Injections) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Large Volume Parenteral (Fluid Balance Injections) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Large Volume Parenteral (Nutritious Injections) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Large Volume Parenteral (Nutritious Injections) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Large Volume Parenteral (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Large Volume Parenteral (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Large Volume Parenteral (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Large Volume Parenteral (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Large Volume Parenteral (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Large Volume Parenteral (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: North America: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: North America: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: United States: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: United States: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Canada: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Canada: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Asia-Pacific: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Asia-Pacific: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: China: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: China: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Japan: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Japan: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: India: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: India: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: South Korea: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: South Korea: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Australia: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Australia: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Indonesia: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Indonesia: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Others: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Others: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Europe: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Europe: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Germany: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Germany: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: France: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: France: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: United Kingdom: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: United Kingdom: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Italy: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Italy: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Spain: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Spain: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Russia: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Russia: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Others: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Others: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Latin America: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Latin America: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Brazil: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Brazil: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Mexico: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Mexico: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Others: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Others: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Middle East and Africa: Large Volume Parenteral Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Middle East and Africa: Large Volume Parenteral Market: Breakup by Country (in %), 2025
  • Figure 85: Middle East and Africa: Large Volume Parenteral Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Global: Large Volume Parenteral Industry: SWOT Analysis
  • Figure 87: Global: Large Volume Parenteral Industry: Value Chain Analysis
  • Figure 88: Global: Large Volume Parenteral Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Large Volume Parenteral Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Large Volume Parenteral Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Large Volume Parenteral Market Forecast: Breakup by Volume (in Million USD), 2026-2034
  • Table 4: Global: Large Volume Parenteral Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Large Volume Parenteral Market Forecast: Breakup by End Users (in Million USD), 2026-2034
  • Table 6: Global: Large Volume Parenteral Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Large Volume Parenteral Market: Competitive Structure
  • Table 8: Global: Large Volume Parenteral Market: Key Players